Cucurbitacin lipsome preparation method and formulation
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of cucurbitacin and body composition, which is applied in the field of medicine and can solve the problems of unsuitable for intravenous injection and low encapsulation rate
Inactive Publication Date: 2004-06-16
SHENYANG PHARMA UNIVERSITY
View PDF0 Cites 30 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
There are literatures to make it into liposome (Chinese herbal medicine 1991, 22 (2): 62), but the encapsulation effici
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0020] Embodiment 1: Preparation of cucurbitacin BE (cucurbitacin B content greater than 60%) liposomes
[0021] prescription:
[0022] Cucurbitacin BE 0.01g
[0023] Soy Lecithin 1g
[0024] Proper amount of ethanol
[0025] Phosphate buffer solution of pH 6.8
[0026] Makes 100ml
[0027] Preparation Process:
[0028] Weigh the prescribed amount of soybean lecithin and cucurbitacin BE, put them in a beaker, add an appropriate amount of ethanol to dissolve, add phosphate buffer, and hydrate for 1 to 2 hours to obtain a cucurbitacin liposome solution. The encapsulation efficiency of the obtained liposome was determined, and the encapsulation efficiency was 95.3%.
Embodiment 2
[0029] Embodiment 2: Preparation of cucurbitacin BE (cucurbitacin B content greater than 80%) liposomes
[0030] prescription:
[0031] Cucurbitacin BE 0.1g (10mmol)
[0032] Hydrogenated Soy Lecithin 1g
[0033] Proper amount of ethanol
[0034] Phosphate buffer at pH 7.4
[0035] Makes 100ml
[0036] Preparation process: same as above, encapsulation efficiency is 86.5%.
Embodiment 3
[0037] Embodiment 3: Preparation of cucurbitacin BE (cucurbitacin B content greater than 80%) liposomes
[0038] prescription:
[0039] Cucurbitacin BE 0.02g
[0040] Egg yolk lecithin 4g
[0041] Cholesterol 1g
[0042] Proper amount of ethanol
[0043] pH4 citrate buffer
[0044] Makes 100ml
[0045] Preparation process: same as above, encapsulation efficiency is 83.7%.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a cucurbitacin liposome composition and its preparation, which has rather high encapsulation efficiency, and can be administered through vein, muscle, oral and nasal. The constituent percentage by weight of the composition are, cucurbitacin BE or cucurbitacin B 0.001-0.1%, phospholipids 0.1-10%, cholesterin 0-5%, the phospholipids can be lecithin, di-stearoyl phosphatidyl choline, di- palmityl phosphatidyl choline, di-oleoyl phosphatidyl choline, di- palmityl phosphatidyl ethanolamine, di-stearoyl phosphatidylglycerol. The preparation according to the invention can be prepared in the form of injection, oral liquid, syrup, drop and nasal spray
Description
Technical field: [0001] The invention relates to the technical field of medicine, specifically, it is a cucurbitacin liposome prescription and its preparation using phospholipids and cucurbitacin to form lipids. Background technique: [0002] Cucurbitacin is the extract of traditional Chinese medicine melon stalk (alias: bitter clove), which mainly contains cucurbitacin B, E, etc., and is an active ingredient for treating hepatitis and liver cancer. Cucurbitacin tablets are used to treat chronic hepatitis (Cucurbitacin Tablets Pharmacy Bulletin 1986, 21(6): 357). After clinical trials in 13 hospitals in Shanghai, Beijing, Chongqing and other places, the effective rate is 75.2%, and the marked rate is 44.6%. . It has been observed clinically that cucurbitacin tablets can comprehensively improve the common symptoms and main signs of chronic hepatitis, and have obvious effects of lowering enzyme (S-GPT), lowering turbidity (TTT, ZnTT) and lowering bilirubin. It can cause S-GP...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more